120 related articles for article (PubMed ID: 26961312)
1. Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging Agents.
Calzada V; García MF; Alonso-Martínez LM; Camachoc X; Goicochea E; Fernández M; Castillo AX; Díaz-Miqueli A; Iznaga-Escobar N; Montaña RL; Alonso O; Gambini JP; Cabral P
Anticancer Agents Med Chem; 2016; 16(9):1184-9. PubMed ID: 26961312
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of (99m)Tc chelate-conjugated bevacizumab.
Camacho X; García MF; Calzada V; Fernández M; Porcal W; Alonso O; Gambini JP; Cabral P
Curr Radiopharm; 2013 Mar; 6(1):12-9. PubMed ID: 23035645
[TBL] [Abstract][Full Text] [Related]
3. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
4. A potencial theranostic agent for EGF-R expression tumors: (177)Lu-DOTA-nimotuzumab.
Calzada V; Zhang X; Fernandez M; Diaz-Miqueli A; Iznaga-Escobar N; Deutscher SL; Balter H; Quinn TP; Cabral P
Curr Radiopharm; 2012 Oct; 5(4):318-24. PubMed ID: 22280117
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 99mTc-nimotuzumab with tricarbonyl ion: in vitro and in vivo studies.
Garcia MF; Camacho X; Calzada V; Fernandez M; Porcal W; Alonso O; Gambini JP; Cabral P
Curr Radiopharm; 2012 Jan; 5(1):59-64. PubMed ID: 22074480
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
7. A radiopharmaceutical [
Tang Y; Hu Y; Liu W; Chen L; Zhao Y; Ma H; Yang J; Yang Y; Liao J; Cai J; Chen Y; Liu N
Nucl Med Biol; 2019 Mar; 70():23-31. PubMed ID: 30826708
[TBL] [Abstract][Full Text] [Related]
8. 99mTechnetium- or Cy7-Labeled Fab(Tocilizumab) as Potential Multiple Myeloma Imaging Agents.
Camacho X; Perroni C; Machado CL; de Godoi Carneiro C; de Souza Junqueira M; Faria D; García MF; Fernández M; Oddone N; Benech J; Buchpiguel CA; Cerecetto H; Chammas R; Riva E; Cabral P; Gambini JP
Anticancer Agents Med Chem; 2021; 21(14):1883-1893. PubMed ID: 33397271
[TBL] [Abstract][Full Text] [Related]
9. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
10. Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8.
Rennen HJ; Boerman OC; Oyen WJ; van der Meer JW; Corstens FH
J Nucl Med; 2001 Jan; 42(1):117-23. PubMed ID: 11197959
[TBL] [Abstract][Full Text] [Related]
11. A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives.
Vito A; Alarabi H; Czorny S; Beiraghi O; Kent J; Janzen N; Genady AR; Al-Karmi SA; Rathmann S; Naperstkow Z; Blacker M; Llano L; Berti PJ; Valliant JF
PLoS One; 2016; 11(12):e0167425. PubMed ID: 27936007
[TBL] [Abstract][Full Text] [Related]
12. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Evaluation of
Hartimath SV; Alizadeh E; Solomon VR; Chekol R; Bernhard W; Hill W; Parada AC; Barreto K; Geyer CR; Fonge H
J Nucl Med; 2019 Aug; 60(8):1103-1110. PubMed ID: 30655327
[TBL] [Abstract][Full Text] [Related]
14. Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments.
Tang Y; Scollard D; Chen P; Wang J; Holloway C; Reilly RM
Nucl Med Commun; 2005 May; 26(5):427-32. PubMed ID: 15838425
[TBL] [Abstract][Full Text] [Related]
15. Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.
Rennen HJ; van Eerd JE; Oyen WJ; Corstens FH; Edwards DS; Boerman OC
Bioconjug Chem; 2002; 13(2):370-7. PubMed ID: 11906276
[TBL] [Abstract][Full Text] [Related]
16. Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody.
Schechter NR; Yang DJ; Azhdarinia A; Kohanim S; Wendt R; Oh CS; Hu M; Yu DF; Bryant J; Ang KK; Forster KM; Kim EE; Podoloff DA
Anticancer Drugs; 2003 Jan; 14(1):49-56. PubMed ID: 12544258
[TBL] [Abstract][Full Text] [Related]
17. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
[TBL] [Abstract][Full Text] [Related]
18. Development of a (99m)Tc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors.
Shamshirian D; Erfani M; Beiki D; Fallahi B; Shafiei M
Ann Nucl Med; 2015 Oct; 29(8):709-20. PubMed ID: 26152564
[TBL] [Abstract][Full Text] [Related]
19.
Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
Anticancer Agents Med Chem; 2018; 18(9):1295-1302. PubMed ID: 29521248
[TBL] [Abstract][Full Text] [Related]
20. Imaging CXCR4 Expression with (99m)Tc-Radiolabeled Small-Interference RNA in Experimental Human Breast Cancer Xenografts.
Fu P; Tian L; Cao X; Li L; Xu P; Zhao C
Mol Imaging Biol; 2016 Jun; 18(3):353-9. PubMed ID: 26452556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
